Taking advantage of tandem mass tag (TMT)-based quantitative proteomics, we identified a possible binding partner of β-catenin: R-cadherin (Cadherin-4), which was shown to be a tumor suppressor in breast, colorectal, and gastric cancer [54,55,56]. This evidence concerns the gene CDH4 and neoplasm.